Home › Atopic Dermatitis (Eczema) › California
Atopic Dermatitis (Eczema) clinical trials in California
30 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in California.
Cities in California
- Los Angeles11 studies
- San Diego10 studies
- Huntington Beach8 studies
- Sacramento8 studies
- Santa Monica6 studies
- Santa Clarita6 studies
- Fremont4 studies
- San Francisco4 studies
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
- First OC Dermatology, Irvine
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 72 · All sexes · Updated Sep 29, 2026 · NCT06808477This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Kern Research, Inc.- Site Number : 8400047, Bakersfield
- Center for Dermatology Clinical Research- Site Number : 8400014, Fremont
- Dermatology Research Associates - Los Angeles- Site Number : 8400020, Los Angeles
- and 4 more
RecruitingObservational study
Ages 12 and older · All sexes · Updated Sep 29, 2026 · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Fountain Valley
- Novartis Investigative Site, Los Angeles
- Novartis Investigative Site, Sacramento
- and 2 more
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Beverly Hills
- Enveda Investigative Site, Fremont
- Enveda Investigative Site, San Diego
- and 3 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07298395First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- Alliance Clinical West Hills (Focus Clinical Research), West Hills
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07527923A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Investigational Drug Service - Rady Childrens Hospital-San Diego, San Diego
- University of California, San Diego/ Rady Children's Hospital - San Diego, San Diego
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Sep 25, 2026 · NCT06807281A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Marvel Clinical Research, Huntington Beach
- Metropolis Dermatology - DTLA, Los Angeles
- Northridge Clinical Trials, Northridge
- and 1 more
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Sep 25, 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Fountain Valley
- Investigational Site, Los Angeles
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07003425The Impact of Dietary Salt on the Severity of Eczema
- San Francisco VA Medical Center, San Francisco
- UCSF Mt Zion Campus, San Francisco
RecruitingPhase 4Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07447063The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
- UCSF Mt Zion Campus, San Francisco
- San Francisco VA Medical Center, San Francisco
RecruitingPhase 4Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07487831A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
- UCLA Division of Dermatology, Los Angeles
- Dermatology Research Associate, Los Angeles
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07223697A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Northridge Clinical Trials, Northridge
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 4, 2026 · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Marvel Research, LLC, Huntington Beach
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- and 4 more
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
- Allergy and Asthma Medical Group and Research Center, San Diego
RecruitingObservational study
Ages 12 and older · All sexes · Updated Aug 17, 2026 · NCT06899204Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
- Integrative Skin Science and Research, Sacramento
RecruitingPhase 4
Ages 12 and older · All sexes · Updated Aug 13, 2026 · NCT07560618A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 1, Lancaster
- Inmagene Site 23, Los Angeles
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Encinitas
- Enveda Investigative Site, Los Angeles
- Enveda Investigative Site, Northridge
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07643766A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Stanford University School of Medicine /ID# 269622, Palo Alto
- Integrative Skin Science and Research /ID# 265108, Sacramento
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Aug 6, 2026 · NCT06461897FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- Anaheim Clinical Trials, LLC, Anaheim
- TCR Medical Corporation, San Diego
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Jul 22, 2026 · NCT06564389Sodium in the Skin and Atopic Dermatitis
- San Francisco VA Medical Center, San Francisco
- UCSF Mt Zion Campus, San Francisco
RecruitingObservational studyHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Jul 14, 2026 · NCT06998446A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Palo Alto
- Leo Pharma Investigational site, Sacramento
- Leo Pharma Investigational site, San Diego
RecruitingPhase 3
6 Months – 11 Years · All sexes · Updated Jul 7, 2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Exalt Clinical Research /ID# 281611, Chula Vista
- Private Practice - Dr. Tooraj Raoof /ID# 263849, Encino
- First OC Dermatology /ID# 263349, Fountain Valley
- and 8 more
RecruitingPhase 3
Ages 18 to 63 · All sexes · Updated Jul 6, 2026 · NCT06389136Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- University of California, San Diego: Dermatology Clinical Trials Unit, San Diego
RecruitingPhase 1
Ages 6 and older · All sexes · Updated Jul 2, 2026 · NCT06504160Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
- First OC Dermatology, Fountain Valley
- Center for Dermatology Clinical Research, Inc., Fremont
- California Allergy and Asthma Medical Group, Los Angeles
- and 1 more
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Jun 15, 2026 · NCT06397911Molecular Signatures of Cutaneous Dupilumab Response
- University of California, San Francisco, San Francisco
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Jun 4, 2026 · NCT05858619A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Marvel Clinical Research, Huntington Beach
- California Allergy and Asthma Medical Group, Los Angeles
- University Dermatology Trials, INC., Newport Beach
- and 4 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 4, 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site - 7074, Corona
- Galderma Investigational Site 8636, Fountain Valley
- Galderma Investigational Site 8224, Fremont
- and 4 more
RecruitingObservational study
Ages 12 and older · All sexes · Updated Mar 13, 2026 · NCT06988605Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
- Corvus Clinical Trials, South San Francisco
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 5, 2026 · NCT07441395Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
- University of California San Diego (UCSD), La Jolla
RecruitingObservational study
All ages · Women · Updated Jan 28, 2025 · NCT05938478A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
- Physioseq, LLC /ID# 267266, Sacramento
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jan 24, 2025 · NCT06524635From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.